Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes
Smoking
About this trial
This is an interventional basic science trial for Smoking focused on measuring electronic cigarettes, e-cigarettes, combustible cigarettes, second-hand smoke, environmental tobacco smoke, tobacco-burning
Eligibility Criteria
Inclusion Criteria:
- Able to read, understand, and willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English.
- Generally healthy males or females, 21 years of age or older at Screening.
Able to meet cohort-specific requirements as follows:
Cohort 1 - Leading U.S. tobacco-burning non-menthol cigarette, and
Cohort 2 - Leading U.S. tobacco-burning menthol cigarette:
- self-reports at the Screening Visit smoking at least 5 cigarettes per day and inhaling the smoke, for at least 3 months prior to Screening
- self-reports smoking Leading U.S. tobacco-burning non-menthol cigarette or Leading U.S. tobacco-burning menthol cigarette as usual brand (UB) cigarettes [UB cigarette is defined as the cigarette brand style currently smoked most frequently by the participant];
Cohort 3 - Electronic cigarette #1 smokers, and
Cohort 4 - Electronic cigarette #2 smokers:
- self-reports at the Screening Visit smoking a non-menthol e-cigarette at least once per day, for at least 3 months prior to Screening;
- willing to switch from using their current e-cigarette brand style to using a different e-cigarette brand style during the study;
Cohort 5 - Electronic cigarette #3 smokers:
- self-reports at the Screening Visit smoking a menthol e-cigarette at least once per day, for at least 3 months prior to Screening;
- willing to switch from using their current e-cigarette brand style to using a different e-cigarette brand style during the study;
Cohort 6 - U.S Market-sample electronic cigarette smokers:
- self-reports at the Screening Visit smoking the selected U.S. market-sample e-cigarettes (menthol or non-menthol) at least once per day, for at least three months prior to Screening;
- willing to continue exclusive use of their preferred style (flavor) of e-cigarette during the study.
- Females of childbearing potential must be willing to use a form of contraception acceptable to the Investigator from the time of signing informed consent until study discharge or be surgically sterile for at least 90 days prior to enrollment;
- Able to safely perform the required study procedures, as determined by the Investigator.
Exclusion Criteria:
- Clinically significant or unstable/uncontrolled acute or chronic medical conditions at Screening, as determined by the Investigator, that would preclude a participant from participating safely in the study (e.g., hypertension, asthma, or other lung disease; cardiac disease; neurological disease; or psychiatric disorders) based on screening assessments such as safety labs and medical history or physical examination at Enrollment;
- Self-reports or safety labs indicate diabetes;
- At risk for heart disease, as determined by the Investigator;
- Use of medicine for treatment of depression or asthma;
- Systolic blood pressure of ≥150 mmHg or a diastolic blood pressure of ≥95 mmHg, measured after being seated for 5 minutes;
- Postponing a decision to quit smoking (defined as planning a quit attempt within 30 days of the Screening Visit) to participate in this study;
- Employed by a tobacco company, the study site, or environmental test chamber vendor;
- Females who have a positive pregnancy test, are pregnant, breastfeeding, or intend to become pregnant during the course of the study;
- History of claustrophobia;
- Regularly exposed to solvent fumes or gasoline (e.g., painter, gas-station mini mart employee);
- Determined by the Investigator to be inappropriate for this study, including a participant who is unable to communicate or unwilling to cooperate with the clinical staff.
Sites / Locations
- Clinical Research Atlanta
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Active Comparator
Active Comparator
Experimental
Experimental
Experimental
Experimental
Leading U.S. tobacco-burning non-menthol cigarette
Leading U.S. tobacco-burning menthol cigarette
Electronic cigarette #1
Electronic cigarette #2
Electronic cigarette #3
U.S. Market-sample electronic cigarettes (two brands)
Leading U.S. non-menthol cigarette
Leading U.S. menthol cigarette
VUSE® (menthol flavor, 29 mg nicotine)
VUSE® (original flavor, 29 mg nicotine)
VUSE® (original flavor, 14 mg nicotine)
blu™ (any variety) and NJOY® (any variety)